Penn Medicine Provider
Neurology
Aaron C. W. Lasker, MD
5.0
(584)
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Director, Huntington’s Disease Center of Excellence
  • Assistant Professor of Clinical Neurology

Education and training

  • Medical School: Tufts University School of Medicine
  • Residency: Brown University
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: Beth Israel Deaconess Medical Center

What my patients think about me

Average Rating
5.0

584 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
amazing visit. dr. lasker was incredibly competent, helpful and dedicated.
May 2025
5.0
5.0
i have been seeing dr. lasker since my diagnosis in 2019. i appreciate him very much.
May 2025
5.0
5.0
took time, answered questions
May 2025
5.0
5.0
love dr lasker

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lasker is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Deik A, Aamodt W, Cadet C, Lasker A, Oliver A, Spindler M, Tropea TF, Vaswani P, Siderowf A. An open-label pilot study to examine the safety, tolerability and efficacy of deutetrabenazine inisolated dystonia , Movement Disorders Clinical Practice: 2025

C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic , Movement Disorders Society, Annual Congress 2024, Philadelphia PA: 2024

Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E, Zhang H, Paul RA, Han N, Zack R, Brody EM, Albuja I, James J, Spindler M, Deik A, Aamodt WW, Dahodwala N, Hamedani A, Lasker A, Hurtig H, Stern M, Weintraub D, Vaswani P, Willis AW, Siderowf A, Xie SX, Van Deerlin V, Chen-Plotkin AS. Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level , npj Parkinson's Disease, 10(1): 2024,97

Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA Disparities in Genetic Testing for Neurologic Disorders , Neurology, 102(6): 2024

Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA. Genetic Testing in Adults with neurologic disorders: indications, approach, and clinical impacts , Journal of Neurology, 217(2): 2024,733-747

Deik A, Spindler M, Lasker A, Vaswani P, Aamodt W, Tropea T A phase I/II open-label study to define the safety, tolerability and clinical activity of deutetrabenazine (AUstedo) in adult study subjects with DYsTonia (the AUDYT trial) , PAS Congress 2024 in Cartagena, Colombia: 2024

Allan Cole Parkinson's and Palliative Care , PDwise.com: 2022

Shaji A, M Solanki N, Ocasio Y, Kaur P, Muller E, Mendez A, Lasker A Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients , Movement Disorders Society, 2022, Annual Congress - Madrid: 2022

Shaji A, M Solanki N, Ocasio Y, Kaur P, Muller E, Mendez A, Lasker A Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients , American Neurological Association, 2022 Annual Meeting: 2022

Ashton C, Tacci C, Laracuente R, Sorberg E, Solis-Cohen L, Horn S, Lasker A, Vanderhorst V, Shih L Spatio-temporal Analysis and Modeling of Gait in Parkinson’s Disease. , American Neurological Association, Annual Meeting: 2016